Literature DB >> 22624714

S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.

Jiehui Deng1, Yong Liu1, Heehyoung Lee1, Andreas Herrmann1, Wang Zhang1, Chunyan Zhang1, Shudan Shen1, Saul J Priceman1, Maciej Kujawski1, Sumanta K Pal2, Andrew Raubitschek1, Dave S B Hoon3, Stephen Forman4, Robert A Figlin5, Jie Liu6, Richard Jove7, Hua Yu8.   

Abstract

Recent studies underscore the importance of myeloid cells in rendering distant organs hospitable for disseminating tumor cells to colonize. However, what enables myeloid cells to have an apparently superior capacity to colonize distant organs is unclear. Here, we show that S1PR1-STAT3 upregulation in tumor cells induces factors that activate S1PR1-STAT3 in various cells in premetastatic sites, leading to premetastatic niche formation. Targeting either S1PR1 or STAT3 in myeloid cells disrupts existing premetastatic niches. S1PR1-STAT3 pathway enables myeloid cells to intravasate, prime the distant organ microenvironment and mediate sustained proliferation and survival of their own and other stromal cells at future metastatic sites. Analyzing tumor-free lymph nodes from cancer patients shows elevated myeloid infiltrates, STAT3 activity, and increased survival signal.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22624714      PMCID: PMC3360884          DOI: 10.1016/j.ccr.2012.03.039

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  50 in total

1.  Stat3 as an oncogene.

Authors:  J F Bromberg; M H Wrzeszczynska; G Devgan; Y Zhao; R G Pestell; C Albanese; J E Darnell
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

2.  Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses.

Authors:  Sindy H Wei; Hugh Rosen; Melanie P Matheu; M Germana Sanna; Sheng-Kai Wang; Euijung Jo; Chi-Huey Wong; Ian Parker; Michael D Cahalan
Journal:  Nat Immunol       Date:  2005-11-06       Impact factor: 25.606

3.  Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.

Authors:  Akira Orimo; Piyush B Gupta; Dennis C Sgroi; Fernando Arenzana-Seisdedos; Thierry Delaunay; Rizwan Naeem; Vincent J Carey; Andrea L Richardson; Robert A Weinberg
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

4.  Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity.

Authors:  Marcin Kortylewski; Maciej Kujawski; Tianhong Wang; Sheng Wei; Shumin Zhang; Shari Pilon-Thomas; Guilian Niu; Heidi Kay; James Mulé; William G Kerr; Richard Jove; Drew Pardoll; Hua Yu
Journal:  Nat Med       Date:  2005-11-20       Impact factor: 53.440

5.  Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target.

Authors:  Roberto Chiarle; William J Simmons; Honjying Cai; Girish Dhall; Alberto Zamo; Regina Raz; James G Karras; David E Levy; Giorgio Inghirami
Journal:  Nat Med       Date:  2005-05-15       Impact factor: 53.440

6.  Role of Stat3 in regulating p53 expression and function.

Authors:  Guilian Niu; Kenneth L Wright; Yihong Ma; Gabriela M Wright; Mei Huang; Rosalyn Irby; Jon Briggs; James Karras; W Douglas Cress; Drew Pardoll; Richard Jove; Jiangdong Chen; Hua Yu
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

7.  Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages.

Authors:  Barbara Visentin; John A Vekich; Bradley J Sibbald; Amy L Cavalli; Kelli M Moreno; Rosalia G Matteo; William A Garland; Yiling Lu; Shuangxing Yu; Hassan S Hall; Vikas Kundra; Gordon B Mills; Roger A Sabbadini
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

8.  A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses.

Authors:  Shaoguang Wu; Ki-Jong Rhee; Emilia Albesiano; Shervin Rabizadeh; Xinqun Wu; Hung-Rong Yen; David L Huso; Frederick L Brancati; Elizabeth Wick; Florencia McAllister; Franck Housseau; Drew M Pardoll; Cynthia L Sears
Journal:  Nat Med       Date:  2009-08-23       Impact factor: 53.440

9.  Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.

Authors:  L Holmgren; M S O'Reilly; J Folkman
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

10.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.

Authors:  Rosandra N Kaplan; Rebecca D Riba; Stergios Zacharoulis; Anna H Bramley; Loïc Vincent; Carla Costa; Daniel D MacDonald; David K Jin; Koji Shido; Scott A Kerns; Zhenping Zhu; Daniel Hicklin; Yan Wu; Jeffrey L Port; Nasser Altorki; Elisa R Port; Davide Ruggero; Sergey V Shmelkov; Kristian K Jensen; Shahin Rafii; David Lyden
Journal:  Nature       Date:  2005-12-08       Impact factor: 49.962

View more
  113 in total

1.  Sphingosine-1-Phosphate Receptor-1 Promotes Environment-Mediated and Acquired Chemoresistance.

Authors:  Veronica Lifshitz; Saul J Priceman; Wenzhao Li; Gregory Cherryholmes; Heehyoung Lee; Adar Makovski-Silverstein; Lucia Borriello; Yves A DeClerck; Hua Yu
Journal:  Mol Cancer Ther       Date:  2017-07-17       Impact factor: 6.261

Review 2.  Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond.

Authors:  Gregory T Kunkel; Michael Maceyka; Sheldon Milstien; Sarah Spiegel
Journal:  Nat Rev Drug Discov       Date:  2013-08-19       Impact factor: 84.694

3.  Breast Cancer Metastasis.

Authors:  Mi Young Kim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Stat3 inhibits Beclin 1 expression through recruitment of HDAC3 in nonsmall cell lung cancer cells.

Authors:  Li-Jun Miao; Feng-Xiang Huang; Zhen-Tao Sun; Rui-Xia Zhang; Shi-Fu Huang; Jing Wang
Journal:  Tumour Biol       Date:  2014-04-24

5.  Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes.

Authors:  Toshiro Hara; Hiroki J Nakaoka; Tetsuro Hayashi; Kouhei Mimura; Daisuke Hoshino; Masahiro Inoue; Fumitaka Nagamura; Yoshinori Murakami; Motoharu Seiki; Takeharu Sakamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-15       Impact factor: 11.205

6.  S1PR1 is crucial for accumulation of regulatory T cells in tumors via STAT3.

Authors:  Saul J Priceman; Shudan Shen; Lin Wang; Jiehui Deng; Chanyu Yue; Maciej Kujawski; Hua Yu
Journal:  Cell Rep       Date:  2014-03-13       Impact factor: 9.423

7.  p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion.

Authors:  Bangxing Hong; Haiyan Li; Mingjun Zhang; Jingda Xu; Yong Lu; Yuhuan Zheng; Jianfei Qian; Jeffrey T Chang; Jing Yang; Qing Yi
Journal:  Int J Cancer       Date:  2014-05-16       Impact factor: 7.396

8.  Th22 cells control colon tumorigenesis through STAT3 and Polycomb Repression complex 2 signaling.

Authors:  Danfeng Sun; Yanwei Lin; Jie Hong; Haoyan Chen; Nisha Nagarsheth; Dongjun Peng; Shuang Wei; Emina Huang; Jingyuan Fang; Ilona Kryczek; Weiping Zou
Journal:  Oncoimmunology       Date:  2015-09-02       Impact factor: 8.110

9.  Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.

Authors:  Dongjun Peng; Takashi Tanikawa; Wei Li; Lili Zhao; Linda Vatan; Wojciech Szeliga; Shanshan Wan; Shuang Wei; Yin Wang; Yan Liu; Elzbieta Staroslawska; Franciszek Szubstarski; Jacek Rolinski; Ewelina Grywalska; Andrzej Stanisławek; Wojciech Polkowski; Andrzej Kurylcio; Celina Kleer; Alfred E Chang; Max Wicha; Michael Sabel; Weiping Zou; Ilona Kryczek
Journal:  Cancer Res       Date:  2016-04-06       Impact factor: 12.701

10.  Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma.

Authors:  Shuyun Rao; Kathy Q Cai; Jason E Stadanlick; Noa Greenberg-Kushnir; Nehal Solanki-Patel; Sang-Yun Lee; Shawn P Fahl; Joseph R Testa; David L Wiest
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.